0.1831

7.90% -0.0157

After Hours: .18 -0.0031 -1.69%

Clearmind Medicine Inc (CMND)

Overview News Price History Why CMND Down? Discussions Forecast Stock Split

Clearmind Medicine Inc stock is traded at $0.1831, with a volume of 4.18M. It is down -7.90% in the last 24 hours and down -82.22% over the past month. Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Previous Close:

$0.1988

Open:

$0.21075

24h Volume:

4.18M

Relative Volume:

0.51

Market Cap:

$1.76M

Revenue:

Net Income/Loss:

$-6.78M

P/E Ratio:

-0.00429

EPS:

-42.6996

Net Cash Flow:

$-4.67M

1W Performance:

-35.80%

1M Performance:

-82.22%

6M Performance:

-81.69%

1Y Performance:

-86.34%

1-Day Range:

$0.1735

$0.217

1-Week Range:

$0.1735

$0.3975

52-Week Range:

$0.1735

$2.18

Clearmind Medicine Inc Stock (CMND) Company Profile

Name

Clearmind Medicine Inc

Sector

Healthcare (1129)

Industry

Biotechnology (632)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CMND's Discussions on Twitter

Compare CMND with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CMND Clearmind Medicine Inc	0.1831	2.10M	0	-6.78M	-4.67M	-42.70
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Clearmind Medicine Inc Stock (CMND) Latest News

Nov 20, 2025

Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah - Investing.com Nigeria

Nov 20, 2025

What macro factors could drive Clearmind Medicine Inc. (CWY0) stock higherAnalyst Downgrade & Consistent Profit Trade Alerts - newser.com

Nov 20, 2025

Can Clearmind Medicine Inc. (CWY0) stock survive global slowdownSell Signal & High Return Trade Opportunity Guides - newser.com

Nov 20, 2025

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - The Manila Times

Nov 20, 2025

SciSparc: Neurothera Labs Announces Israeli Patent - GlobeNewswire

Nov 20, 2025

Clearmind begins phase I/IIa trial for alcohol disorder drug at Hadassah By Investing.com - Investing.com South Africa

Nov 20, 2025

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site - The Manila Times

Nov 20, 2025

Clearmind Medicine files Israeli patent for depression treatment - MSN

Nov 20, 2025

Will Clearmind Medicine Inc. stock reach all time highs in 2025July 2025 EndofMonth & Real-Time Volume Triggers - newser.com

Nov 20, 2025

Clearmind Medicine announces results from Phase I/IIa trial of CMND-100 - MSN

Nov 20, 2025

Nov 19, 2025